cryptocurrency computer People searches

The Bank of Japan believes that the cost of waiting for the next rate hike is not high, but it is also open to raising interest rates this month. According to informed sources, Bank of Japan officials believe that there is almost no cost to wait before raising interest rates, and they are still open to raising interest rates next week, depending on data and market development. According to people familiar with the matter, even if the Bank of Japan decides to wait until January next year or a little longer before raising interest rates, the relevant authorities believe that this will not bring huge costs, because there are signs that there is little risk of inflation overshoot. According to people familiar with the matter, officials think it is only a matter of time before the next rate hike, because the economy and inflation are in line with their forecasts. According to people familiar with the matter, officials will make a final decision only after carefully evaluating the data and financial markets before announcing the policy decision in December. Bank of Japan Governor Kazuo Ueda and his committee will discuss next week whether it is necessary to raise the benchmark interest rate from 0.25%. Unlike the situation in July, the yen did not show a strong weakness, so the Bank of Japan believes that the risk of the yen pushing up inflation has weakened.Market News: Apple is cooperating with Broadcom around artificial intelligence (AI) chips. Apple chips may be ready for production in 2026.R&F Properties announced on the Hong Kong Stock Exchange that the High Court ordered that the hearing of R&F Hong Kong's petition be postponed until December 16, 2024.

The International Finance Association predicts that the capital flowing into emerging markets will decrease by 24% in 2025, and the International Finance Association predicts that the capital flowing into emerging markets will decrease by 24% to $716 billion in 2025. It is estimated that in 2025, Mexico's portfolio inflow will drop by a quarter to $1 billion, and in 2025, India's portfolio inflow will more than triple to $22 billion.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Southbound funds bought a net of 7.285 billion yuan today, and southbound funds bought a net of 7.285 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), TraHK and China Mobile received net purchases of HK$ 2.719 billion and HK$ 352 million respectively; Tencent Holdings ranked first in net sales, amounting to HK$ 491 million; In terms of Hong Kong Stock Connect (Shenzhen Stock Connect), TraHK and Hang Seng China Enterprises received net purchases of HK$ 2.501 billion and HK$ 665 million respectively; Meituan -W ranked first in net sales, amounting to HK$ 602 million.

*ST Zhongli: The company's reorganization plan was approved by the court. *ST Zhongli announced that the company's reorganization plan had been approved by the Suzhou Intermediate People's Court and the reorganization procedure was terminated. The content of the reorganization plan is consistent with the previously disclosed draft, aiming at comprehensively solving the historical problems of the company's 1.805 billion yuan capital occupation and illegal guarantee. In the implementation stage of the reorganization plan, the company will be responsible for implementation and the manager will be responsible for supervision. If it is successfully implemented, it will help to optimize the company's asset-liability structure, enhance its sustainable operation and profitability, and have a significant impact on the relevant financial indicators in 2024.Traders increased their bets on the Fed's interest rate cut. After the CPI report was released, swap traders increased their bets on the Fed's interest rate cut before the end of 2025. They now predict that by that time, they will cut interest rates by 87 basis points, which means that the Federal Reserve will cut interest rates by 25 basis points next week. In 2025, there will be another two interest rate cuts of 25 basis points each time, which is less than the four times proposed by Fed officials in the latest quarterly bitmap in September.Modern Investment: Xu Qing, the independent director of the company, was subject to disciplinary review and supervision investigation. According to the announcement of Modern Investment, Xu Qing, the independent director of the company, was suspected of serious violation of discipline and law, and is currently subject to disciplinary review by the Disciplinary Committee of Hunan Branch of Industrial and Commercial Bank of China and supervision investigation by Zhuzhou Municipal Supervision Committee. Xu Qing did not hold any other positions in the company except as an independent director, chairman of the Nomination Committee of the Board of Directors, member of the Strategy Committee of the Board of Directors and member of the Audit Committee of the Board of Directors, and did not participate in the daily operation and management of the company. The company will pay attention to the subsequent progress and fulfill its information disclosure obligations in a timely manner in strict accordance with relevant regulations.